 | • レポートコード：QYR9ST00110 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のクロピドグレル市場について調査・分析し、以下の構成でお届け致します。クロピドグレルの種類別には、25mg、75 mg、300 mgに、用途別には、病院、プライベートクリニック、小売薬局、オンライン薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別クロピドグレル売上データ ・地域別クロピドグレル市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別クロピドグレル市場規模：25mg、75 mg、300 mg ・用途別クロピドグレル市場規模：病院、プライベートクリニック、小売薬局、オンライン薬局、その他 ・主要メーカーの企業情報：Sanofi (France)、Shenzhen Salubris Pharmaceuticals (China)、Lepu Medical Technology (China) ・クロピドグレルの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are in clinical trials. As a result, the drug did not face much competition and has taken over the global market, with its array of application constantly expanding.
The substantial and high-level evidence gathered over the years support the use of Clopidogrel for reduction of mortality and morbidity patients with acute coronary syndrome, myocardial infarction, and a number of other indications. As a result, the drug has developed a formidable presence in the global market over the years. Moreover, the drug’s relative ease of use, low rate of incidence of adverse reactions, and good tolerability have made it the de-facto antiplatelet agent for the reduction of atherosclerotic events in patients.
These factors have helped the global Clopidogrel market to tread along an excellent growth path in the past few years and the market is expected to embark upon a healthy growth path in the next few years as well. However, the overall profitability of the market has reduced to a certain extent owing to entry of a number of generic products post the patent expiry of Clopidogrel manufacture in 2013. Nevertheless, the vast pool of patients prescribed Clopidogrel on an annual basis across the globe will allow market players excellent growth prospects in the next few years.
The global Clopidogrel market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Clopidogrel market based on company, product type, end user and key regions.
This report studies the global market size of Clopidogrel in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Clopidogrel in these regions.
This research report categorizes the global Clopidogrel market by top players/brands, region, type and end user. This report also studies the global Clopidogrel market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi (France)
Shenzhen Salubris Pharmaceuticals (China)
Lepu Medical Technology (China)
Market size by Product
25mg
75 mg
300 mg
Market size by End User
Hospitals
Private Clinics
Retail Pharmacies
Online Pharmacies
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Clopidogrel market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Clopidogrel market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Clopidogrel companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Clopidogrel submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Clopidogrel are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Clopidogrel market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Clopidogrel Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Clopidogrel Market Size Growth Rate by Product
1.4.2 25mg
1.4.3 75 mg
1.4.4 300 mg
1.5 Market by End User
1.5.1 Global Clopidogrel Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Private Clinics
1.5.4 Retail Pharmacies
1.5.5 Online Pharmacies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Clopidogrel Market Size
2.1.1 Global Clopidogrel Revenue 2014-2025
2.1.2 Global Clopidogrel Sales 2014-2025
2.2 Clopidogrel Growth Rate by Regions
2.2.1 Global Clopidogrel Sales by Regions
2.2.2 Global Clopidogrel Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Clopidogrel Sales by Manufacturers
3.1.1 Clopidogrel Sales by Manufacturers
3.1.2 Clopidogrel Sales Market Share by Manufacturers
3.1.3 Global Clopidogrel Market Concentration Ratio (CR5 and HHI)
3.2 Clopidogrel Revenue by Manufacturers
3.2.1 Clopidogrel Revenue by Manufacturers (2014-2019)
3.2.2 Clopidogrel Revenue Share by Manufacturers (2014-2019)
3.3 Clopidogrel Price by Manufacturers
3.4 Clopidogrel Manufacturing Base Distribution, Product Types
3.4.1 Clopidogrel Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Clopidogrel Product Type
3.4.3 Date of International Manufacturers Enter into Clopidogrel Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Clopidogrel Sales by Product
4.2 Global Clopidogrel Revenue by Product
4.3 Clopidogrel Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Clopidogrel Breakdown Data by End User
6 North America
6.1 North America Clopidogrel by Countries
6.1.1 North America Clopidogrel Sales by Countries
6.1.2 North America Clopidogrel Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Clopidogrel by Product
6.3 North America Clopidogrel by End User
7 Europe
7.1 Europe Clopidogrel by Countries
7.1.1 Europe Clopidogrel Sales by Countries
7.1.2 Europe Clopidogrel Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Clopidogrel by Product
7.3 Europe Clopidogrel by End User
8 Asia Pacific
8.1 Asia Pacific Clopidogrel by Countries
8.1.1 Asia Pacific Clopidogrel Sales by Countries
8.1.2 Asia Pacific Clopidogrel Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Clopidogrel by Product
8.3 Asia Pacific Clopidogrel by End User
9 Central & South America
9.1 Central & South America Clopidogrel by Countries
9.1.1 Central & South America Clopidogrel Sales by Countries
9.1.2 Central & South America Clopidogrel Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Clopidogrel by Product
9.3 Central & South America Clopidogrel by End User
10 Middle East and Africa
10.1 Middle East and Africa Clopidogrel by Countries
10.1.1 Middle East and Africa Clopidogrel Sales by Countries
10.1.2 Middle East and Africa Clopidogrel Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Clopidogrel by Product
10.3 Middle East and Africa Clopidogrel by End User
11 Company Profiles
11.1 Sanofi (France)
11.1.1 Sanofi (France) Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi (France) Clopidogrel Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi (France) Clopidogrel Products Offered
11.1.5 Sanofi (France) Recent Development
11.2 Shenzhen Salubris Pharmaceuticals (China)
11.2.1 Shenzhen Salubris Pharmaceuticals (China) Company Details
11.2.2 Company Business Overview
11.2.3 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Products Offered
11.2.5 Shenzhen Salubris Pharmaceuticals (China) Recent Development
11.3 Lepu Medical Technology (China)
11.3.1 Lepu Medical Technology (China) Company Details
11.3.2 Company Business Overview
11.3.3 Lepu Medical Technology (China) Clopidogrel Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Lepu Medical Technology (China) Clopidogrel Products Offered
11.3.5 Lepu Medical Technology (China) Recent Development
12 Future Forecast
12.1 Clopidogrel Market Forecast by Regions
12.1.1 Global Clopidogrel Sales Forecast by Regions 2019-2025
12.1.2 Global Clopidogrel Revenue Forecast by Regions 2019-2025
12.2 Clopidogrel Market Forecast by Product
12.2.1 Global Clopidogrel Sales Forecast by Product 2019-2025
12.2.2 Global Clopidogrel Revenue Forecast by Product 2019-2025
12.3 Clopidogrel Market Forecast by End User
12.4 North America Clopidogrel Forecast
12.5 Europe Clopidogrel Forecast
12.6 Asia Pacific Clopidogrel Forecast
12.7 Central & South America Clopidogrel Forecast
12.8 Middle East and Africa Clopidogrel Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Clopidogrel Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Clopidogrel Product Picture
Table Clopidogrel Market Segments
Table Key Manufacturers Clopidogrel Covered
Table Global Clopidogrel Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Clopidogrel Sales Market Share by Product 2014-2025
Figure 25mg Product Picture
Table Major Manufacturers of 25mg
Figure 75 mg Product Picture
Table Major Manufacturers of 75 mg
Figure 300 mg Product Picture
Table Major Manufacturers of 300 mg
Table Global Clopidogrel Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Private Clinics
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Others
Figure Clopidogrel Report Years Considered
Figure Global Clopidogrel Market Size 2014-2025 (Million US$)
Figure Global Clopidogrel Sales 2014-2025 (K Units)
Table Global Clopidogrel Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Clopidogrel Sales by Regions 2014-2019 (K Units)
Table Global Clopidogrel Sales Market Share by Regions 2014-2019
Figure Global Clopidogrel Sales Market Share by Regions 2014-2019
Figure 2018 Global Clopidogrel Sales Market Share by Regions
Table Global Clopidogrel Revenue by Regions 2014-2019 (Million US$)
Table Global Clopidogrel Revenue Market Share by Regions 2014-2019
Figure Global Clopidogrel Revenue Market Share by Regions 2014-2019
Figure 2018 Global Clopidogrel Revenue Market Share by Regions
Table Global Clopidogrel Sales by Manufacturers (2014-2019) (K Units)
Table Global Clopidogrel Sales Share by Manufacturers (2014-2019)
Figure Global Clopidogrel Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Clopidogrel Revenue by Manufacturers (2014-2019) (Million USD)
Table Clopidogrel Revenue Share by Manufacturers (2014-2019)
Figure Clopidogrel Value Share by Manufacturers in 2018
Table Key Manufacturers Clopidogrel Price (2014-2019) (USD/Unit)
Table Clopidogrel Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Clopidogrel Product Type
Table Date of International Manufacturers Enter into Clopidogrel Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Clopidogrel Sales by Product (2014-2019) (K Units)
Table Global Clopidogrel Sales Share by Product (2014-2019)
Figure Global Clopidogrel Sales Market Share by Product (2014-2019)
Figure Global Clopidogrel Sales Market Share by Product in 2018
Table Global Clopidogrel Revenue by Product (2014-2019) (Million US$)
Table Global Clopidogrel Revenue Share by Product (2014-2019)
Figure Global Clopidogrel Revenue Market Share by Product (2014-2019)
Figure Global Clopidogrel Revenue Market Share by Product in 2018
Table Clopidogrel Price by Product 2014-2019 (USD/Unit)
Table Global Clopidogrel Sales by End User (2014-2019) (K Units)
Table Global Clopidogrel Sales Share by End User (2014-2019)
Figure Global Sales Clopidogrel Market Share by End User (2014-2019)
Figure Global Sales Clopidogrel Market Share by End User in 2018
Figure North America Clopidogrel Sales Growth Rate 2014-2019 (K Units)
Figure North America Clopidogrel Revenue Growth Rate 2014-2019 (Million US$)
Table North America Clopidogrel Sales by Countries (2014-2019) (K Units)
Table North America Clopidogrel Sales Market Share by Countries (2014-2019)
Figure 2018 North America Clopidogrel Sales Market Share by Countries
Table North America Clopidogrel Revenue by Countries (2014-2019) (Million US$)
Table North America Clopidogrel Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Clopidogrel Revenue Market Share by Countries
Figure United States Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure United States Clopidogrel Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Canada Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Table North America Clopidogrel Sales by Product (2014-2019) (K Units)
Table North America Clopidogrel Sales Market Share by Product (2014-2019)
Figure 2018 North America Clopidogrel Market Share by Product
Table North America Clopidogrel Sales by End User (2014-2019) (K Units)
Table North America Clopidogrel Sales Market Share by End User (2014-2019)
Figure 2018 North America Clopidogrel Market Share by End User
Figure Europe Clopidogrel Sales Growth Rate 2014-2019 (K Units)
Figure Europe Clopidogrel Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Clopidogrel Sales by Countries (2014-2019) (K Units)
Table Europe Clopidogrel Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Clopidogrel Sales Market Share by Countries
Table Europe Clopidogrel Revenue by Countries (2014-2019) (Million US$)
Table Europe Clopidogrel Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Clopidogrel Revenue Market Share by Countries
Figure Germany Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Germany Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure France Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure France Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure UK Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Italy Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Russia Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Clopidogrel Sales by Product (2014-2019) (K Units)
Table Europe Clopidogrel Sales Market Share by Product (2014-2019)
Figure 2018 Europe Clopidogrel Market Share by Product
Table Europe Clopidogrel Sales by End User (2014-2019) (K Units)
Table Europe Clopidogrel Sales Market Share by End User (2014-2019)
Figure 2018 Europe Clopidogrel Market Share by End User
Figure Asia Pacific Clopidogrel Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Clopidogrel Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Clopidogrel Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Clopidogrel Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Clopidogrel Sales Market Share by Countries
Table Asia Pacific Clopidogrel Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Clopidogrel Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Clopidogrel Revenue Market Share by Countries
Figure China Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure China Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Japan Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Korea Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure India Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure India Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Australia Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Clopidogrel Sales by Product (2014-2019) (K Units)
Table Asia Pacific Clopidogrel Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Clopidogrel Market Share by Product
Table Asia Pacific Clopidogrel Sales by End User (2014-2019) (K Units)
Table Asia Pacific Clopidogrel Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Clopidogrel Market Share by End User
Figure Central & South America Clopidogrel Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Clopidogrel Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Clopidogrel Sales by Countries (2014-2019) (K Units)
Table Central & South America Clopidogrel Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Clopidogrel Sales Market Share by Countries
Table Central & South America Clopidogrel Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Clopidogrel Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Clopidogrel Revenue Market Share by Countries
Figure Brazil Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Clopidogrel Sales by Product (2014-2019) (K Units)
Table Central & South America Clopidogrel Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Clopidogrel Market Share by Product
Table Central & South America Clopidogrel Sales by End User (2014-2019) (K Units)
Table Central & South America Clopidogrel Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Clopidogrel Market Share by End User
Figure Middle East and Africa Clopidogrel Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Clopidogrel Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Clopidogrel Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Clopidogrel Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Clopidogrel Sales Market Share by Countries
Table Middle East and Africa Clopidogrel Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Clopidogrel Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Clopidogrel Revenue Market Share by Countries
Figure GCC Countries Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Clopidogrel Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Clopidogrel Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Clopidogrel Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Clopidogrel Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Clopidogrel Market Share by Product
Table Middle East and Africa Clopidogrel Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Clopidogrel Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Clopidogrel Market Share by End User
Table Sanofi (France) Company Details
Table Sanofi (France) Clopidogrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi (France) Recent Development
Table Shenzhen Salubris Pharmaceuticals (China) Company Details
Table Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shenzhen Salubris Pharmaceuticals (China) Recent Development
Table Lepu Medical Technology (China) Company Details
Table Lepu Medical Technology (China) Clopidogrel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lepu Medical Technology (China) Recent Development
Table Global Clopidogrel Sales Forecast by Regions 2019-2025 (K Units)
Table Global Clopidogrel Sales Market Share Forecast by Regions 2019-2025
Table Global Clopidogrel Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Clopidogrel Revenue Market Share Forecast by Regions 2019-2025
Table Global Clopidogrel Sales Forecast by Product 2019-2025 (K Units)
Table Global Clopidogrel Sales Market Share Forecast by Product 2019-2025
Table Global Clopidogrel Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Clopidogrel Revenue Market Share Forecast by Product 2019-2025
Table Global Clopidogrel Sales Forecast by End User 2019-2025 (K Units)
Table Global Clopidogrel Sales Market Share Forecast by End User 2019-2025
Figure North America Clopidogrel Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Clopidogrel Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Clopidogrel Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Clopidogrel Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Clopidogrel Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Clopidogrel Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Clopidogrel Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Clopidogrel Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Clopidogrel Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Clopidogrel Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Clopidogrel Value Chain
Table Clopidogrel Customers List
Table Clopidogrel Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
調剤薬局の世界市場：インサイト・予測 Compounding pharmacies produce drugs prepared by licensed pharmacist or under the guidance of a physician, tailored or customized to meet the needs of individual patients. Compounded drugs are prepared by altering, combining, or mixing the necessary active pharmaceutical ingredients in appropriate p…- HIV薬の世界市場：インサイト・予測 HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.One …
- トリプトレリンの世界市場：インサイト・予測 Triptorelin is a decapeptide analogue of Luteinising Hormone-Releasing Hormone (LHRH, also called gonadotropin-releasing hormone [GnRH]). Triptorelin is extensively used in palliative treatment of hormone dependent advanced prostate cancer.The global Triptorelin market is valued at xx million US$ in…
- 抗自殺薬の世界市場：インサイト・予測 Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for p…
- 胃腸治療及び診断の世界市場：インサイト・予測 Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as ir…